CYP2D6 and chlorpheniramine pharmacokinetics.

被引：0
|
作者：
Yasuda, SU [1 ]
Zannikos, P [1 ]
Young, AE [1 ]
Fried, KM [1 ]
Wainer, JW [1 ]
Woosley, RL [1 ]
机构：
[1] Georgetown Univ, Med Ctr, Dept Pharmacol, Washington, DC 20007 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P7 / P7
页数：1
相关论文
共 50 条
  • [31] CYP2D6*10 genetic polymorphisms and Bisoprolol's pharmacokinetics
    Zhang, Zhi-guo
    Wang, Jing
    Li, Hong-ying
    Sun, Shu-bo
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 145 - 145
  • [32] EFFECTS OF CYP2D6 GENETIC POLYMORPHISM ON THE PHARMACOKINETICS OF TOLPERISONE IN KOREANS
    Byeon, J.
    Lee, H.
    Choi, C.
    Jang, C.
    Bae, J.
    Lee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S24 - S24
  • [33] Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects
    Ophelia Qi Ping Yin
    Valiant Wah Lun Mak
    Miao Hu
    Benny Siu Pong Fok
    Moses Sing Sum Chow
    Brian Tomlinson
    European Journal of Clinical Pharmacology, 2012, 68 : 943 - 949
  • [34] Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol
    Kirchheiner, Julia
    Keulen, Jan-Tobias H. A.
    Bauer, Steffen
    Roots, Ivar
    Brockmoeller, Juerge
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (01) : 78 - 83
  • [35] Effect of CYP2D6 genetic polymorphism on the population pharmacokinetics of tipifarnib
    Perez-Ruixo, Juan Jose
    Zannikos, Peter
    Ozdemir, Vural
    Franc, Monique A.
    Francke, Stephan
    Piotrovsky, Vladimir
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (05) : 681 - 691
  • [36] Impact of CYP2D6 Genetic Polymorphism on Tramadol Pharmacokinetics and Pharmacodynamics
    Siew Hua Gan
    Rush Ismail
    Wan Aasim Wan Adnan
    Wan Zulmi
    Molecular Diagnosis & Therapy, 2007, 11 (3) : 171 - 181
  • [37] Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics
    Sehrt, Daniel
    Meineke, Ingolf
    Tzvetkov, Mladen
    Gueltepe, Senol
    Brockmoeller, Jurgen
    PHARMACOGENOMICS, 2011, 12 (06) : 783 - 795
  • [38] Relevance of CYP2D6 for risperidone pharmacokinetics, pharmacodynamics and adverse reactions
    LLerena, Adrian
    Dorado, Pedro
    Penas-LLedo, Eva M.
    PHARMACOGENOMICS, 2011, 12 (03) : 311 - 311
  • [39] PHARMACOKINETICS OF TOLPERISONE IS SIGNIFICANTLY DIFFERENT IN THREE CYP2D6 GENOTYPES
    Kim, Y.
    Lee, Y.
    Lee, Y.
    Byeon, J.
    Kim, S.
    Lee, J.
    Lee, S.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 168 - 168
  • [40] Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects
    Yin, Ophelia Qi Ping
    Mak, Valiant Wah Lun
    Hu, Miao
    Fok, Benny Siu Pong
    Chow, Moses Sing Sum
    Tomlinson, Brian
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (06) : 943 - 949
12345